By RUMMAN AHMED BANGALORE—India's government is facing stiff resistance from foreign and local pharmaceutical companies over its plan to severely limit prices for drugs.

MUMBAI: Health activists and cancer patients in the US have pounced on Swiss drug multinational Novartis for the high price of its famous, multi-billion dollar anti-cancer drug Glivec, a development which challenges pharma MNCs' claims of cheap access ...

| ZURICH (Reuters) - Swiss drugmaker Novartis said on Thursday it would investigate alleged drug approval irregularities in India after a parliamentary report found the country's regulator colluded with pharmaceutical firms to speed up approval ...

* Report highlights failings in approving drugs in India * Novartis to investigate allegations in report ZURICH May 10 (Reuters) - Swiss drugmaker Novartis said on Thursday it would investigate alleged drug approval irregularities in India after a ...

Mumbai: Prices of cancer medicines are dropping dramatically after India allowed Hyderabad's Natco Pharma Ltd to sell a copy of German firm Bayer AG's patented cancer drug Nexavar under compulsory licensing norms.